The HIV-1 Integrase Mutations Y143C/R Are an Alternative Pathway for Resistance to Raltegravir and Impact the Enzyme Functions

Sandrine Reigadas, Guerric Anies, Bernard Masquelier et al. · 2010

Read The HIV-1 Integrase Mutations Y143C/R Are an Alternative Pathway for Resistance to Raltegravir and Impact the Enzyme Functions by Sandrine Reigadas, Guerric Anies, Bernard Masquelier et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010311.txt.

Description

The authors were Sandrine Reigadas, Guerric Anies, Bernard Masquelier, and others. Their 2010 PLOS ONE study tracked HIV drug resistance in three patients. Raltegravir blocks HIV integrase, the enzyme that inserts viral DNA into human DNA. Resistance arises through mutations in that enzyme, and one common mutation was being replaced by changes at position 143 in these patients.

The team cloned and analyzed the Y143C and Y143R variants. They showed these mutations form an alternative resistance pathway and change enzyme function. Knowing escape routes helps doctors sequence HIV drugs after a first failure.

Catalog record

CREATORSandrine Reigadas, Guerric Anies, Bernard Masquelier et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010311

Browse the full library · About the Tower of Babel